NCT00124176|CompletedPhase 4ResultsDMC
Loading search results
Sponsor study identifier
interventional
81
1 country
1
Study Start
April 2004
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
February 2006
Actual (reported)Study Completion
February 2006
Actual (reported)This study will use a randomized, double-blind, controlled trial design in order to assess the safety and efficacy of levalbuterol (LEV) compared to racemic albuterol (RAC) when delivered continuously in a high-dose regimen for children with severe exacerbations of asthma. Primary hypothesis
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 2006
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 2004
Date type not reportedThis date has not been verified as actual or estimated.
July 25, 2005
Actual (reported)July 27, 2005
Actual (reported)February 2006
Actual (reported)February 2006
Actual (reported)March 14, 2013
Actual (reported)Duration of Continuous Therapy
standard intention to treat (ITT) analysis
During hospitalization
Change in Pediatric Asthma Severity Score
After 12 hours of continuous nebulization
Heart Rate
After 12 hours of continuous nebulization
Serum Potassium Levels
After 12 hours of continuous nebulization
Serum Albuterol S Isomer Levels
After 6 hours of continuous albuterol
Nebulized levalbuterol 10mg/hr given continuously
Racemic albuterol 20mg/hr given continuously
20mg/hr continuous racemic albuterol
10mg/hr continuous nebulized levalbuterol
The Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
Joseph J Zorc, MD
Children's Hospital of Philadelphia
81 participants (actual enrollment reported by the registry).
First Submitted
July 25, 2005
First Posted
July 27, 2005
Study Start
April 2004
Date type not reportedThis date has not been verified as actual or estimated.
The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
February 2006
Actual (reported)Study Completion
February 2006
Actual (reported)Last Updated
March 14, 2013
Results First Posted
March 14, 2013
Record last verified: 2012-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: